We’re thrilled to announce that our CEO, Katleen, has been awarded the Top Innovative Chief Executive Officer in Life Sciences at BIO-Europe 2025, presented by the European Investment Bank (EIB). This prestigious recognition highlights her exceptional leadership and unwavering commitment to advancing innovation in life sciences and women’s health.
In her words:
“This recognition celebrates tremendous leadership, but none of it would be possible without two things: financial support and an extraordinary team, getting up every single day to make the impossible possible and striving to improve patient lives.”
Katleen’s energy, hard work, and passionate leadership have been instrumental in shaping the culture at midiagnostics — a culture rooted in curiosity, scientific excellence, and a shared mission to transform patient care through next-generation diagnostic technologies.
The acknowledgment from the EIB not only celebrates visionary leadership but also underscores the importance of empowering female leaders and fostering innovation in areas that directly impact human health. As an organization, we are proud to stand alongside partners who share our belief that meaningful change comes from collaboration, dedication, and bold ideas.
At midiagnostics, we remain committed to pushing scientific and technological boundaries — developing fast, reliable, and accessible diagnostic solutions that can make a real difference in people’s lives.
Congratulations, Katleen, on this well-deserved recognition, and thank you to the European Investment Bank for championing innovation and women’s leadership in science. Here’s to continuing the journey of impact, together.
